Last edition
News about "Dr Reddy "
Dr Reddy's Q3 FY26 Net Profit Falls Fourteen Percent Despite Revenue Growth
Dr Reddy’s Laboratories reported consolidated revenue of INR eight thousand seven hundred twenty seven crore in the third quarter of financial year twenty six, registering year on year growth.
Dr Reddy | 23/01/2026 | By Darshana | 115
Dr. Reddy's Wins European Approval for Denosumab Biosimilar
Dr. Reddy’s Laboratories has received approval from the European Commission for its denosumab biosimilar, used in the treatment of osteoporosis and cancer-related bone conditions.
Dr. Reddy | 25/11/2025 | By Darshana | 135
USFDA completes inspection at Dr Reddy's Laboratories Ltd's Bollaram API unit
USFDA completes inspection at Dr Reddy's Laboratories Ltd's Bollaram API unit
Dr Reddy | 19/06/2023 | By Sudeep Soparkar | 1146
Dr Reddy's acquires trademark rights of breast cancer drug PRIMCYV from Pfizer Products India
Following the trademark rights acquisition, Dr Reddy’s will manufacture the Active Pharmaceutical Ingredient (API) and finished drug at its state-of-the-art facilities
Dr Reddy | 17/01/2023 | By Sudeep Soparkar | 656
Dr Reddy's Labs buys injectable product portfolio from Eton Pharma
Dr Reddy’s acquired the Eton portfolio for an upfront payment of approximately $5 million in cash, plus contingent payments of up to $45 million.
Dr Reddy | 27/06/2022 | By Sudeep Soparkar | 636
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy